Form 4: Clorox Director Christopher J. Williams Expands Equity Holdings Through Deferred Stock Units

Clorox Co. Director Christopher J. Williams increased his beneficial ownership of the company's deferred stock units through dividend reinvestment and in lieu of quarterly director's fees, bringing his total holdings to 19,046.2446 units.

Summary

• Christopher J. Williams, a Director of Clorox Co. (CLX), increased his beneficial ownership of Deferred Stock Units (DSUs).
• On May 9, 2025, Williams acquired 168.6631 DSUs through dividend reinvestment, pursuant to the Independent Directors' Deferred Compensation Plan.
• On June 30, 2025, Williams received an additional 247.223 DSUs in lieu of quarterly director's fees.
• Following these transactions, Williams' total beneficial ownership of DSUs stands at 19,046.2446 units.
• These Deferred Stock Units are convertible on a 1-for-1 basis into Clorox Common Stock and will be settled upon Williams' retirement or other termination of service as a Director.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine filing, but the director increasing their stake (even through compensation) can be seen as a positive signal of alignment with shareholder interests.

Positives

• Director Christopher J. Williams is increasing his stake in Clorox Co. through the acquisition of additional Deferred Stock Units, aligning his interests with shareholders.
• The acquisition of DSUs through dividend reinvestment and in lieu of cash fees demonstrates a commitment to long-term investment in the company.

Future Outlook

The Deferred Stock Units acquired by Director Williams are structured to be settled 100% in Clorox common stock upon his retirement or other termination of service as a Director, indicating a long-term vesting and ownership structure.

Industry Context

This Form 4 filing reflects a routine compensation and ownership update for a director at a consumer goods company like Clorox. Such filings are common across industries as part of executive and director compensation plans, often involving equity-based awards to align interests with shareholders.

Related Party Transactions

• Director Christopher J. Williams acquired Deferred Stock Units from Clorox Co. as part of his compensation, including dividend reinvestment and in lieu of quarterly director's fees, under the Independent Directors' Deferred Compensation Plan.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value through equity ownership.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The Deferred Stock Units will be settled in Clorox common stock upon Christopher J. Williams' retirement or other termination of service as a Director.

Key Dates

Keywords

Clorox Co, CLX, Christopher J. Williams, Director, SEC Form 4, Deferred Stock Units, DSUs, Insider Trading, Stock Ownership, Dividend Reinvestment, Director Compensation